Doctors Demand Restrictions On Another Execution Drug
Over the past year numerous pharmaceutical companies have tried to distance themselves from lethal injections (sometimes voluntarily, sometimes under pressure). Until now, all these efforts involved the use of an anesthetic, the first drug in 3-drug execution protocols, or the only drug in one-drug protocols. First Hospira, then Novartis, Lundbeck, Kayem and Naari have all objected to the use of their anesthetic products in U.S. executions. (...)
